503A Available In ALL 50 STATES!

Preview text: 503A Available in ALL 50 States! 96 We have worked hard to bring you expanded pharmacy…

MedShiftRxTuesday, Sep 1, 2026 at 3:07 PM EasternHubSpot
MedShiftRx503A Available In ALL 50 STATES!
Subject
503A Available In ALL 50 STATES!
Preview text
503A Available in ALL 50 States! 96 We have worked hard to bring you expanded pharmacy…
From
info@medshiftrx.com
Sent
Tue Sep 1, 2026, 3:07 PM ET
Sent to
medshiftrx.com, store.medshift.com
Size
69 KB
Images
8
Links
10, 3 of them buttons
Subject length
32 characters

Against MedShiftRx's usual

Sent in its busiest hour, 3 PM, which holds 50% of its emails. The subject is 32 characters; its average is 41.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From
MedShiftRx <[email protected]>
Subject
503A Available In ALL 50 STATES!
Date
Tue, 1 Sep 2026 15:07:06 -0400
Message-ID domain
45330025m.medshift.com
Return-Path domain
45330025m.medshift.com
DKIM signature
d=45330025m.medshift.com s=hs1; d=medshiftrx.com s=hs1-45330025
List-Unsubscribe
Present, one-click
Feedback-ID sender
HubSpot

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

Report this email

Sent just before and after

Sep 9, 2026 3:16 PMThe webinar ended, but the education didn’t.
Sep 4, 2026 7:18 PM15% Off ALL Peptides ⚡
Sep 3, 2026 3:08 PMFall Is Coming. Is Your Practice Ready? 🍂
Sep 1, 2026 3:07 PM503A Available In ALL 50 STATES! (this email)
Aug 31, 2026 12:02 AMAre You Overpaying For Bacteriostatic Water? 💦
Aug 27, 2026 11:11 AMHAPPENING TODAY: PRP WEBINAR
Aug 25, 2026 3:08 PMPeptide Auto-Injection Pens NOW AVAILABLE on MRx

More from MedShiftRx

All MedShiftRx emails

Get the Black Friday insights

We're collecting every Black Friday email from more than 50,000 brands as it lands. Get what we find: who starts first, the biggest discounts, and the subject lines that stand out.

Free. You'll get a confirmation email first, and you can unsubscribe anytime.